Option chain shows key data for D-MARKET Electronic's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for D-MARKET Electronic.

D-MARKET Electronic (NASDAQ:HEPS) Stock, Option Chain

D-MARKET Electronic

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues, and other revenues.

Fintech news covering the emerging Financial Technology services sector

Fintech

News

Penny Stocks

Small Cap

HEPS

Turkish e-commerce platform, Hepsiburada (NASDAQ: HEPS) signed a five-year agreement with Visa (NYSE: V) to ensure that the former’s digital prepaid cards are accepted worldwide for both online and physical purchases.

Visa Agrees To Partner With Turkey-Based Hepsiburada To Expand Digital Prepaid Cards

Contracts

INTC

Turkish E-Commerce Platform Hepsiburada Partners With Intel To Help SMEs Go Digital

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABVC

ADSK

ADTX

ADXS

AEHR

AMPG

ASND

ASTS

AUID

AVNW

AVTE

BASE

BLCT

BLUW

BURL

BYSI

CABA

CFLT

CMPI

COTY

DFNS

DLTR

DOCS

EFTR

FATBB

GAMB

GWAC

HAIN

HLBZ

HUIZ

JWEL

KOPN

MDIA

MRAM

NAKD

OPNT

PLCE

PRPO

PSTG

QTRX

Lordstown Motors Corp. - Class A Common Stock

RIDE

RNXT

SAVA

SGOC

SLQT

SNTG

SPRT

TSRI

VMAR

Gainers


	Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume.


63 Biggest Movers From Yesterday

D-Market Electronic Services & Trading - American Depositary Shares

D-MARKET Electronic Services & Trading

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) in relation to its major competitors in the Semiconductors &amp; Semiconductor Equipment industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company's performance in the industry.
<h3>NVIDIA Background</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVIDIA Corp</td>
<td>57.60</td>
<td>54.31</td>
<td>32.02</td>
<td>30.94%</td>
<td>$19.71</td>
<td>$22.57</td>
<td>122.4%</td>
</tr>
<tr>
<td>Taiwan Semiconductor Manufacturing Co Ltd</td>
<td>30.08</td>
<td>7.92</td>
<td>11.92</td>
<td>8.36%</td>
<td>$555.05</td>
<td>$439.35</td>
<td>38.95%</td>
</tr>
<tr>
<td>Broadcom Inc</td>
<td>131.87</td>
<td>11.61</td>
<td>16.17</td>
<td>-2.77%</td>
<td>$6.39</td>
<td>$8.36</td>
<td>47.27%</td>
</tr>
<tr>
<td>Advanced Micro Devices Inc</td>
<td>121.77</td>
<td>3.92</td>
<td>9.26</td>
<td>1.36%</td>
<td>$1.55</td>
<td>$3.42</td>
<td>17.57%</td>
</tr>
<tr>
<td>Texas Instruments Inc</td>
<td>36.84</td>
<td>10.47</td>
<td>11.58</td>
<td>7.86%</td>
<td>$2.09</td>
<td>$2.47</td>
<td>-8.41%</td>
</tr>
<tr>
<td>Qualcomm Inc</td>
<td>17.26</td>
<td>6.52</td>
<td>4.47</td>
<td>11.46%</td>
<td>$3.21</td>
<td>$5.78</td>
<td>18.69%</td>
</tr>
<tr>
<td>ARM Holdings PLC</td>
<td>221.04</td>
<td>23.37</td>
<td>40.19</td>
<td>1.83%</td>
<td>$0.11</td>
<td>$0.81</td>
<td>4.71%</td>
</tr>
<tr>
<td>Micron Technology Inc</td>
<td>140.53</td>
<td>2.42</td>
<td>4.38</td>
<td>1.99%</td>
<td>$3.63</td>
<td>$2.74</td>
<td>93.27%</td>
</tr>
<tr>
<td>Analog Devices Inc</td>
<td>63.56</td>
<td>2.98</td>
<td>10.86</td>
<td>1.11%</td>
<td>$1.04</td>
<td>$1.31</td>
<td>-24.84%</td>
</tr>
<tr>
<td>Microchip Technology Inc</td>
<td>45.22</td>
<td>5.57</td>
<td>6.45</td>
<td>1.24%</td>
<td>$0.34</td>
<td>$0.67</td>
<td>-48.37%</td>
</tr>
<tr>
<td>ON Semiconductor Corp</td>
<td>16.70</td>
<td>3.34</td>
<td>3.97</td>
<td>4.75%</td>
<td>$0.63</td>
<td>$0.8</td>
<td>-19.21%</td>
</tr>
<tr>
<td>Monolithic Power Systems Inc</td>
<td>63.14</td>
<td>11.62</td>
<td>13.44</td>
<td>6.35%</td>
<td>$0.17</td>
<td>$0.34</td>
<td>30.59%</td>
</tr>
<tr>
<td>STMicroelectronics NV</td>
<td>10.08</td>
<td>1.25</td>
<td>1.62</td>
<td>1.98%</td>
<td>$0.74</td>
<td>$1.23</td>
<td>-26.63%</td>
</tr>
<tr>
<td>ASE Technology Holding Co Ltd</td>
<td>19.35</td>
<td>2.22</td>
<td>1.16</td>
<td>3.16%</td>
<td>$28.59</td>
<td>$26.43</td>
<td>3.85%</td>
</tr>
<tr>
<td>First Solar Inc</td>
<td>15.92</td>
<td>2.61</td>
<td>5.16</td>
<td>4.22%</td>
<td>$0.45</td>
<td>$0.45</td>
<td>10.81%</td>
</tr>
<tr>
<td>United Microelectronics Corp</td>
<td>10.71</td>
<td>1.50</td>
<td>2.40</td>
<td>4.0%</td>
<td>$29.73</td>
<td>$20.43</td>
<td>5.99%</td>
</tr>
<tr>
<td>Skyworks Solutions Inc</td>
<td>22.61</td>
<td>2.11</td>
<td>3.22</td>
<td>0.95%</td>
<td>$0.18</td>
<td>$0.43</td>
<td>-15.9%</td>
</tr>
<tr>
<td>MACOM Technology Solutions Holdings Inc</td>
<td>122.65</td>
<td>8.20</td>
<td>12.86</td>
<td>2.67%</td>
<td>$0.05</td>
<td>$0.11</td>
<td>33.47%</td>
</tr>
<tr>
<td>Universal Display Corp</td>
<td>33.31</td>
<td>4.96</td>
<td>12.28</td>
<td>4.29%</td>
<td>$0.08</td>
<td>$0.13</td>
<td>14.57%</td>
</tr>
<tr>
<td>Lattice Semiconductor Corp</td>
<td>49.75</td>
<td>9.95</td>
<td>12.50</td>
<td>1.03%</td>
<td>$0.03</td>
<td>$0.09</td>
<td>-33.87%</td>
</tr>
<tr>
<td>Average</td>
<td>61.7</td>
<td>6.45</td>
<td>9.68</td>
<td>3.47%</td>
<td>$33.37</td>
<td>$27.12</td>
<td>7.5%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>When analyzing NVIDIA, the following trends become evident: 
<ul>
<li>
The Price to Earnings ratio of 57.6 is 0.93x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
With a Price to Book ratio of 54.31, which is 8.42x the industry average, NVIDIA might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
With a relatively high Price to Sales ratio of 32.02, which is 3.31x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
The Return on Equity (ROE) of 30.94% is 27.47% above the industry average, highlighting efficient use of equity to generate profits.
</li>
<li>
With lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $19.71 Billion, which is 0.59x below the industry average, the company may face lower profitability or financial challenges.
</li>
<li>
Compared to its industry, the company has lower gross profit of $22.57 Billion, which indicates 0.83x below the industry average, potentially indicating lower revenue after accounting for production costs.
</li>
<li>
With a revenue growth of 122.4%, which surpasses the industry average of 7.5%, the company is demonstrating robust sales expansion and gaining market share.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732201208_0_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio assesses the extent to which a company relies on borrowed funds compared to its equity.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In terms of the Debt-to-Equity ratio, NVIDIA stands in comparison with its top 4 peers, leading to the following comparisons:
<ul>
<li>
NVIDIA is in a relatively stronger financial position compared to its top 4 peers, as evidenced by its lower debt-to-equity ratio of 0.17.
</li>
<li>
This implies that the company relies less on debt financing and has a more favorable balance between debt and equity.
</li>
</ul>
<h3>Key Takeaways</h3>
For NVIDIA in the Semiconductors &amp; Semiconductor Equipment industry, the PE, PB, and PS ratios indicate that the stock is relatively undervalued compared to its peers. However, the high ROE, low EBITDA, low gross profit, and high revenue growth suggest that the company is performing well and has strong growth potential within the industry sector.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NVDA

Industry Comparison: Evaluating NVIDIA Against Competitors In Semiconductors &amp; Semiconductor Equipment Industry

Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) price has increased 7.03% over the past 24 hours to $3,341.75. Over the past week, ETH has experienced an uptick of over 8.0%, moving from $3,101.02 to its current price. As it stands right now, the coin's all-time high is $4,878.26. 
The chart below compares the price movement and volatility for Ethereum over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1732201208_0.png" alt="price_chart" />
The trading volume for the coin has increased 12.0% over the past week, while the overall circulating supply of the coin has decreased 0.89%. The current market cap ranking for ETH is #2 at $403.32 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1732201208_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

Test0.580874103561221: Ethereum Rises More Than 7% In 24 hours

Brazil Potash Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRO#NYSE">GRO</a>) IPO will take place November, 22 on the NYSE exchange under the ticker GRO.
The company is offering shares at an expected price between $15.00 and $18.00 per share with an insider lock-up period of 180 days ending on May 21, 2025.
See also: <a href="https://www.benzinga.com/calendars/ipos">Benzinga IPO Calendar</a>
<h3>About Brazil Potash Corp</h3>
Brazil Potash Corp is a mineral exploration and development company, and their primary mining project is the Autazes Project located in the Amazon potash basin near the city of Autazes in the state of Amazonas, Brazil.
See also: <a href="https://www.benzinga.com/short-interest">Benzinga's Most Shorted Stocks</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IPOs

Brazil Potash Corp To Start Trading Tomorrow

Oppenheimer analyst Brian Bittner maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Outperform and maintains $60 price target.

Price Target

Analyst Ratings

JACK

Oppenheimer Maintains Outperform on Jack In The Box, Maintains $60 Price Target

<a href="https://x.com/EleanorTerrett/status/1859611713579999366" title="https://x.com/EleanorTerrett/status/1859611713579999366">https://x.com/EleanorTerrett/status/1859611713579999366</a>

$BTC

$SOL

Fox Business Reporter, Eleanor Terret, Post On X, "Talks between @SECGov staff and issuers looking to launch a $SOL spot ETF are "progressing" with the SEC now engaging on S-1 applications, according to two people familiar with the matter…"

RBC Capital analyst Leonid Timashev maintains Pyxis Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) with a Outperform and raises the price target from $7 to $10.

PYXS

RBC Capital Maintains Outperform on Pyxis Oncology, Raises Price Target to $10

RBC Capital analyst Arun Viswanathan maintains Berry Global Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>) with a Sector Perform and raises the price target from $69 to $73.

BERY

RBC Capital Maintains Sector Perform on Berry Global Gr, Raises Price Target to $73

Oppenheimer analyst Michael Phillips initiates coverage on Intl General Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) with a Outperform rating and announces Price Target of $30.

Initiation

IGIC

Oppenheimer Initiates Coverage On Intl General Insurance with Outperform Rating, Announces Price Target of $30

SKK Shares Halted On Circuit Breaker To The Upside, Stock Now Up 123.5%

RBC Capital analyst Elvira Scotto reiterates EnLink Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENLC#NYSE">ENLC</a>) with a Sector Perform and maintains $15 price target.

Reiteration

ENLC

RBC Capital Reiterates Sector Perform on EnLink Midstream, Maintains $15 Price Target

JP Morgan analyst Christopher Horvers maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Neutral and lowers the price target from $167 to $139.

JP Morgan Maintains Neutral on Target, Lowers Price Target to $139

SKK Shares Resume Trade Following Circuit Breaker Halt

<ul>
<li>"Channel Therapeutics" reflects the Company's focus on developing therapeutics to treat pain utilizing sodium channel blockade and modulation</li>
<li>New name is in advance of multiple near-term data readouts</li>
</ul>
&nbsp;
Therapeutic Program Update:
<ul>
<li>Depot Program for Postoperative Nerve Blocks – the Company showed a sustained release of drug over a 96-hour period in animals and is currently performing efficacy studies in animals, with results expected imminently. &nbsp;</li>
<li>Eye Pain Program – the eye drops were well tolerated in an animal study and the Company is performing efficacy studies in animal models of eye pain with toxicology studies starting shortly. The results of the efficacy studies are expected in the coming weeks and the toxicology data is expected in late Q1 2025. The Company expects to commence Phase II human proof of concept studies in Q2 2025, with a readout by the end of 2025. &nbsp;</li>
<li>Chronic Pain – the Company is exploring program-specific financing for this program with expectations that the program will be kicked off in Q1 2025.</li>
</ul>

Biotech

General

CHRO

Chromocell Announces Name Change To "Channel Therapeutics Corporation"; Provides Therapeutic Program Updates

JP Morgan analyst Anupam Rama maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Overweight and lowers the price target from $105 to $102.

RARE

JP Morgan Maintains Overweight on Ultragenyx Pharmaceutical, Lowers Price Target to $102

Polymarket bettors are speculating on Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) performance this November, with sharp focus on whether the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42096519/bitcoin-to-reach-190000-this-cycle-michael-terpin-of-transform-group-says">cryptocurrency will surpass $100,000.</a>
Current predictions on the platform <a href="https://polymarket.com/event/will-bitcoin-hit-100k-in-november">show</a> a 79% chance that Bitcoin will breach this milestone, fueled by the asset's recent all-time high of $98,310 and growing optimism in the market.
<h3 class="wp-block-heading">Bettors Lean Toward $105,000, Cautious Beyond</h3>
Beyond the $100,000 mark, Polymarket data <a href="https://polymarket.com/event/what-price-will-bitcoin-hit-in-november">indicates</a> a 46% probability for Bitcoin to hit $105,000 in November, while a rise to $110,000 is pegged at 25%.
However, optimism dims for more ambitious targets—only 9% of bettors see Bitcoin reaching $120,000, and just 1% believe it could hit $150,000 this month.
The cautious sentiment for extreme price hikes highlights the market's view of Bitcoin's upward limits this month, even as the cryptocurrency has shown consistent growth.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42109267/bitcoin-hits-new-all-time-high-above-98000-as-spot-etfs-crack-100-billion-net-asset-value-milestone">Bitcoin Hits New All-Time High Above $98,000 As Spot ETFs Crack $100 Billion Net Asset Value Milestone</a>
<h3 class="wp-block-heading">Institutional Activity And ETF Inflows Boost Optimism</h3>
Bitcoin's rally is being bolstered by significant institutional activity. 
For example, MicroStrategy&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) plans to raise $2.6 billion to purchase more Bitcoin has pushed its market cap past $100 billion. 
Additionally, U.S. Bitcoin spot ETFs recorded $1.84 billion in net inflows over the past three days, showcasing rising demand <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42109267/bitcoin-hits-new-all-time-high-above-98000-as-spot-etfs-crack-100-billion-net-asset-value-milestone">for Bitcoin as an asset class.</a>
These developments, combined with easing global monetary policies, are likely contributing to the bullish outlook for Bitcoin's price trajectory.
Bitcoin isn't the only cryptocurrency drawing attention. Polymarket bettors are also speculating on Ethereum and Solana's November performance. 
For Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), there's a 23% <a href="https://polymarket.com/event/what-price-will-ethereum-hit-in-november">chance </a>of hitting $4,000 in Novem, while Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) bettors assign a 47% <a href="https://polymarket.com/event/what-price-will-solana-hit-in-november?tid=1732196501984">probability </a>to the token crossing $275.
These markets indicate an overall bullish sentiment across major cryptocurrencies.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42071904/blackrock-sees-renewed-sense-of-optimism-around-bitcoin">BlackRock Sees &#8216;Renewed Sense Of Optimism&#8217; Around Bitcoin</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

MSTR

Bitcoin Price Hitting $100,000 In November? Polymarket Traders Speculate It Might Go Even Higher

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
<h3 class="wp-block-heading">Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</h3>
<ul>
<li>Dividend Yield: 6.74%</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $28 to $30 on July 31. This analyst has an accuracy rate of 65%.</li>
<li>Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and boosted the price target from $28 to $29 on May 2. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On Nov. 20, Pfizer announced new Chief Scientific Officer and President, Research &amp; Development.</li>
<li>Benzinga Pro's real-time newsfeed alerted to la<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1">test PFE news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093509/image-218.png" alt="" class="wp-image-658993" style="width:747px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093509/image-218.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093509/image-218-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093509/image-218-768x703.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Patterson Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>)</h3>
<ul>
<li>Dividend Yield: 5.18%</li>
<li>Baird analyst Jeff Johnson maintained a Neutral rating and cut the price target from $30 to $28 on Aug. 29. This analyst has an accuracy rate of 78%.</li>
<li>Morgan Stanley analyst Erin Wright maintained an Equal-Weight rating and cut the price target from $35 to $28 on June 20. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Nov. 13, Patterson Dental extended strategic relationship with PDS Health.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest PDCO news </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="883" height="655" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093944/image-219.png" alt="" class="wp-image-658996" style="width:685px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093944/image-219.png 883w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093944/image-219-300x223.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21093944/image-219-768x570.png 768w" sizes="(max-width: 883px) 100vw, 883px" /></a></figure>
<h3 class="wp-block-heading">CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>)</h3>
<ul>
<li>Dividend Yield: 4.68%</li>
<li>Truist Securities analyst David Macdonald reiterated a Buy rating and cut the price target from $76 to $67 on Nov. 20. This analyst has an accuracy rate of 67%.</li>
<li>UBS analyst Kevin Celiendo maintained a Neutral rating and raised the price target from $60 to $62 on Nov. 7. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On Nov. 18, CVS Health announced the addition of four new directors to its board.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1">in CVS stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="847" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21094238/image-220.png" alt="" class="wp-image-658999" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21094238/image-220.png 847w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21094238/image-220-300x300.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21094238/image-220-150x150.png 150w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21094238/image-220-768x771.png 768w" sizes="(max-width: 847px) 100vw, 847px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42103475/nvidia-deere-and-3-stocks-to-watch-heading-into-thursday">Nvidia, Deere And 3 Stocks To Watch Heading Into Thursday</a></li>
</ul>

PDCO

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields

<a href="https://x.com/CitronResearch/status/1859608654590202325" title="https://x.com/CitronResearch/status/1859608654590202325">https://x.com/CitronResearch/status/1859608654590202325</a>

Short Sellers

Citron Research Posts On X ".. with Bitcoin investing easier than ever (ETFs, $COIN, $HOOD), $MSTR's volume has completely detached from BTC fundamentals. While Citron remains bullish on Bitcoin, we've hedged with a short $MSTR position.."

JP Morgan analyst Anupam Rama maintains Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) with a Overweight and raises the price target from $33 to $38.

SNDX

JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $38

Financial giants have made a conspicuous bearish move on NVIDIA. Our analysis of options history for NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) revealed 509 unusual trades.
Delving into the details, we found 39% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 87 were puts, with a value of $5,771,224, and 422 were calls, valued at $42,566,316.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $0.5 to $280.0 for NVIDIA over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for NVIDIA options trades today is 29645.59 with a total volume of 6,724,021.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for NVIDIA's big money trades within a strike price range of $0.5 to $280.0 over the last 30 days.
<h3>NVIDIA Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732200460_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$33.95</td>
<td>$33.75</td>
<td>$33.84</td>
<td>$150.00</td>
<td>$795.2K</td>
<td>26.7K</td>
<td>543</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$2.9</td>
<td>$2.87</td>
<td>$2.9</td>
<td>$150.00</td>
<td>$219.9K</td>
<td>57.1K</td>
<td>24.2K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$7.85</td>
<td>$7.6</td>
<td>$7.73</td>
<td>$280.00</td>
<td>$181.7K</td>
<td>18.2K</td>
<td>539</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$150.00</td>
<td>$158.2K</td>
<td>57.1K</td>
<td>27.9K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$2.83</td>
<td>$2.8</td>
<td>$2.81</td>
<td>$150.00</td>
<td>$132.6K</td>
<td>57.1K</td>
<td>21.3K</td>
</tr>
</tbody>
</table>

<h3>About NVIDIA</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
In light of the recent options history for NVIDIA, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is NVIDIA Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 48,977,431, the NVDA's price is up by 4.01%, now at $151.74. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 90 days.</li>
</ul>
<h3>What The Experts Say On NVIDIA</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $177.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for NVIDIA, targeting a price of $175. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on NVIDIA, maintaining a target price of $170. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on NVIDIA, maintaining a target price of $167. 
&#x2A; Maintaining their stance, an analyst from Benchmark continues to hold a Buy rating for NVIDIA, targeting a price of $190. 
&#x2A; Maintaining their stance, an analyst from Melius Research continues to hold a Buy rating for NVIDIA, targeting a price of $185. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for NVIDIA, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Decoding NVIDIA's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bearish stance on Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HOOD, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 17 options trades for Robinhood Markets.
This isn't normal.
The overall sentiment of these big-money traders is split between 29% bullish and 64%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $29,800, and 16, calls, for a total amount of $1,056,398.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $40.0 for Robinhood Markets, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Robinhood Markets's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Robinhood Markets's whale activity within a strike price range from $30.0 to $40.0 in the last 30 days. 
<h3>Robinhood Markets Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732200454_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.31</td>
<td>$2.2</td>
<td>$2.2</td>
<td>$39.00</td>
<td>$220.0K</td>
<td>2.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.65</td>
<td>$37.00</td>
<td>$146.0K</td>
<td>22.6K</td>
<td align="right">928</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.15</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$34.00</td>
<td>$127.5K</td>
<td>3.4K</td>
<td align="right">257</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.91</td>
<td>$1.9</td>
<td>$1.9</td>
<td>$40.00</td>
<td>$84.7K</td>
<td>17.7K</td>
<td align="right">957</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$7.95</td>
<td>$7.5</td>
<td>$7.75</td>
<td>$30.00</td>
<td>$77.5K</td>
<td>14.8K</td>
<td align="right">105</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fractional shares, recurring investments, and IPO Access. It earns transaction-based revenues from routing user orders for options, equities, and cryptocurrencies to market makers when a routed order is executed.
Having examined the options trading patterns of Robinhood Markets, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Robinhood Markets</h3>
<ul>
<li>With a trading volume of 2,118,067, the price of HOOD is up by 2.25%, reaching $36.89.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 82 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Robinhood Markets</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $31.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Robinhood Markets with a target price of $26. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Robinhood Markets, maintaining a target price of $36. 
&#x2A; Maintaining their stance, an analyst from Deutsche Bank continues to hold a Buy rating for Robinhood Markets, targeting a price of $32. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Robinhood Markets with a target price of $24. 
&#x2A; An analyst from Needham upgraded its action to Buy with a price target of $40. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Robinhood Markets, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

HOOD

Decoding Robinhood Markets's Options Activity: What's the Big Picture?

Hepsiburada Is An Interesting Growth Stock, But Price May Be High

D-Market (HEPS) has released an update. Hepsiburada, a leading Turkish e-commerce platform, reports significant growth in its ‘Trade and Technology...

Hepsiburada Booms with Empowerment Program Success

D-Market (HEPS) has released an update. D-Market Electronic Services & Trading, also known as Hepsiburada, has announced the updated composition of...

Hepsiburada Revamps Board Committees for Strategic Oversight

D-Market (HEPS) has released an update. D-Market Electronic Services & Trading, operating as Hepsiburada, a leading Turkish e-commerce company, has...

Hepsiburada Boosts BNPL Services with New Securities Issuance

D-Market (HEPS) has released an update. D-Market Electronic Services & Trading, known as Hepsiburada, has announced Hepsifinans, its indirect wholl...

Hepsiburada Subsidiary's Debut Bond Issuance

D-Market (HEPS) has released an update. Hepsiburada's founder and affiliates have agreed to sell all their Class A and B shares to Kazakhstan's Joi...

Hepsiburada Shares Sold to Kaspi.kz, Aims for Continued Growth

Hepsiburada Changes Everything For Kaspi

Jumia (JMIA) and D-MARKET Electronic Services & Trading (HEPS) announced that the companies have entered into a commercial partnership whereby Heps...

Jumia Technologies, Hepsiburada enter commercial partnership

D-MARKET Electronic Services & Trading (HEPS) and Jumia (JMIA) announced that the companies have entered into a commercial partnership whereby Heps...

Hepsiburada, Jumia join forces to unlock broader product selection

D-MARKET Electronic Services & Trading announced the second bond issuance of its indirect wholly owned subsidiary, Hepsi Finansman, at a nominal va...

Hepsiburada announces second bond issuance of Hepsifinans

JMIA

KSPI

Press Releases

Hepsiburada Announces the 18-month Results of the "Trade and Technology Empowerment for the Earthquake Region" Program

Hepsiburada Announces its Board Committees' Composition and Enhanced Risk Committee Function

Bonds

Hepsiburada Announces the Second Issuance of Asset-backed Securities

Hepsiburada Announces the First Bond Issuance of Hepsifinans

Financing

E-commerce champions join forces: Kaspi.kz to become controlling shareholder in Türkiye's Hepsiburada

Hepsiburada announces founder and other affiliates' entry into an agreement with Joint Stock Company Kaspi.kz to sell all their Class A shares and Class B shares

Hepsiburada and Jumia Join Forces to Unlock Broader Product Selection for North African Consumers

Hepsiburada Announces the Second Bond Issuance of Hepsifinans

Hepsiburada to Announce Third Quarter 2024 Results on December 10, 2024

Amazon.com

Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share

Alibaba Gr Hldgs

Baozun

Coupang

Dillard's

1stdibs.com

eBay

Etsy

Global E Online

Groupon

JD.com, Inc. - American Depositary Shares

JD.com

Jumia Technologies AG American Depositary Shares, each representing two Ordinary Shares

Jumia Technologies

Nordstrom

Kohl's

LightInTheBox Holding Co., Ltd. American Depositary Shares, each representing twelve ordinary shares

LightInTheBox Holding

ContextLogic

Macy's

MercadoLibre

MINISO Group Holding Limited American Depositary Shares, each representing four Ordinary Shares

MINISO Group Holding

Ollie's Bargain Outlet Holdings, Inc. - Common Stock

Ollie's Bargain Outlet

PDD Holdings Inc. - American Depositary Shares

PDD Holdings

Qurate Retail, Inc. - Series A Common Stock

Qurate Retail

Qurate Retail, Inc. - Series B Common Stock

Comments

D-MARKET Electronic

D-MARKET Electronic (HEPS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga